Self-reported sleep disturbances in renal transplant recipients

BMC Nephrology

Sabina De Geest²  Reto M Venzin¹  Thomas Fehr⁶  Jürg Steiger³  Terri E Weaver⁴  Christian Cajochen⁷  Anna Wirz-Justice⁷  Daniel P Brunner⁵  Hanna Burkhalter³ 

[1] Division of Nephrology, University Hospital Bern, Bern, Switzerland;Center for Health Services and Nursing Research, KU Leuven, Belgium;Division of Transplant Immunology and Nephrology, University Hospital Basel, Basel, Switzerland;Department of Biobehavioral and Health Sciences, University of Illinois Chicago College of Nursing, Chicago, USA;Centre for Sleep Medicine Hirslanden, Zürich, Switzerland;Division of Nephrology, University Hospital Zürich, Zürich, Switzerland;Centre for Chronobiology, Psychiatric Clinics, University of Basel, Basel, Switzerland

关键词: Daytime sleepiness;    Sleep quality;    Sleep disturbances;    Renal transplantation;   

Others  :  1082819
DOI  :  10.1186/1471-2369-14-220

 received in 2013-06-03, accepted in 2013-10-09,  发布年份 2013

【 摘 要 】

Background

Poor sleep quality (SQ) and daytime sleepiness (DS) are common in renal transplant (RTx) recipients; however, related data are rare. This study describes the prevalence and frequency of self-reported sleep disturbances in RTx recipients.

Methods

This cross-sectional study included 249 RTx recipients transplanted at three Swiss transplant centers. All had reported poor SQ and / or DS in a previous study. With the Survey of Sleep (SOS) self-report questionnaire, we screened for sleep and health habits, sleep history, main sleep problems and sleep-related disturbances. To determine a basis for preliminary sleep diagnoses according to the International Classification of Sleep Disorders (ICSD), 164 subjects were interviewed (48 in person, 116 via telephone and 85 refused). Descriptive statistics were used to analyze the data and to determine the frequencies and prevalences of specific sleep disorders.

Results

The sample had a mean age of 59.1 ± 11.6 years (60.2% male); mean time since Tx was 11.1 ± 7.0 years. The most frequent sleep problem was difficulty staying asleep (49.4%), followed by problems falling asleep (32.1%). The most prevalent sleep disturbance was the need to urinate (62.9%), and 27% reported reduced daytime functionality. Interview data showed that most suffered from the first ICSD category: insomnias.

Conclusion

Though often disregarded in RTx recipients, sleep is an essential factor of wellbeing. Our findings show high prevalences and incidences of insomnias, with negative impacts on daytime functionality. This indicates a need for further research on the clinical consequences of sleep disturbances and the benefits of insomnia treatment in RTx recipients.

【 授权许可】

   
2013 Burkhalter et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Eryilmaz MM, Ozdemir C, Yurtman F, Cilli A, Karaman T: Quality of sleep and quality of life in renal transplantation patients. Transplant Proc 2005, 37(5):2072-2076.
• [2]Kachuee H, Ameli J, Taheri S, Assari S, Riahipour F, Khedmat H, Saadat AR: Sleep quality and its correlates in renal transplant patients. Transplant Proc 2007, 39(4):1095-1097.
• [3]Sabbatini M, Crispo A, Pisani A, Gallo R, Cianciaruso B, Fuiano G, Federico S, Andreucci VE: Sleep quality in renal transplant patients: a never investigated problem. Nephrol Dial Transplant 2005, 20(1):194-198.
• [4]Burkhalter H, Sereika SM, Engberg S, Wirz-Justice A, Steiger J, De Geest S: Validity of 2 sleep quality items to be used in a large cohort study of kidney transplant recipients. Prog Transplant 2011, 21(1):27-35.
• [5]Krystal AD, Edinger JD: Measuring sleep quality. Sleep medicine 2008, 9(Suppl 1):S10-S17.
• [6]Young TB: Epidemiology of daytime sleepiness: definitions, symptomatology, and prevalence. J Clin Psychiatry 2004, 65(Suppl 16):12-16.
• [7]Burkhalter H, Sereika SM, Engberg S, Wirz-Justice A, Steiger J, De Geest S: Sleep quality description based on the Pittsburgh Sleep Quality Index in renal transplant recipients. In Organ Transplantation: Ethical, Legal and Psychosocial Aspects Expanding the European Platform. Volume 2, edn. Edited by Weimar W, Bos MA, Busschbach JJ. Lengerich/Germany: PABST Science Publishers; 2011.
• [8]Burkhalter H, Wirz-Justice A, Cajochen C, Weaver T, Steiger J, Fehr T, Venzin R, De Geest S: Validation of a single item to assess daytime sleepiness for the Swiss Transplant Cohort Study. Prog Transplant 2013, 23(3):220-228.
• [9]Elder SJ, Pisoni RL, Akizawa T, Fissell R, Andreucci VE, Fukuhara S, Kurokawa K, Rayner HC, Furniss AL, Port FK, et al.: Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2008, 23(3):998-1004.
• [10]Kumar B, Tilea A, Gillespie BW, Zhang X, Kiser M, Eisele G, Finkelstein F, Kotanko P, Levin N, Rajagopalan S, et al.: Significance of self-reported sleep quality (SQ) in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study. Clin Nephrol 2010, 73(2):104-114.
• [11]Rodrigue JR, Mandelbrot DA, Hanto DW, Johnson SR, Karp SJ, Pavlakis M: A cross-sectional study of fatigue and sleep quality before and after kidney transplantation. Clin Transplant 2011, 25(1):E13-E21.
• [12]Novak M, Molnar MZ, Ambrus C, Kovacs AZ, Koczy A, Remport A, Szeifert L, Szentkiralyi A, Shapiro CM, Kopp MS, et al.: Chronic insomnia in kidney transplant recipients. Am J Kidney Dis 2006, 47(4):655-665.
• [13]Kovacs AZ, Molnar MZ, Szeifert L, Ambrus C, Molnar-Varga M, Szentkiralyi A, Mucsi I, Novak M: Sleep disorders, depressive symptoms and health-related quality of life–a cross-sectional comparison between kidney transplant recipients and waitlisted patients on maintenance dialysis. Nephrol Dial Transplant 2011, 26(3):1058-1065.
• [14]Silva DS, Andrade Edos S, Elias RM, David-Neto E, Nahas WC, Castro MC: The perception of sleep quality in kidney transplant patients during the first year of transplantation. Clinics 2012, 67(12):1365-1371.
• [15]Molnar MZ, Novak M, Szeifert L, Ambrus C, Keszei A, Koczy A, Lindner A, Barotfi S, Szentkiralyi A, Remport A, et al.: Restless legs syndrome, insomnia, and quality of life after renal transplantation. J Psychosom Res 2007, 63(6):591-597.
• [16]Reimer J, Franke GH, Lutkes P, Kohnle M, Gerken G, Philipp T, Heemann U: Quality of life in patients before and after kidney transplantation. Psychother Psychosom Med Psychol 2002, 52(1):16-23.
• [17]Kosmadakis GC, Medcalf JF: Sleep disorders in dialysis patients. Int J Artif Organs 2008, 31(11):919-927.
• [18]Hanly P: Sleep disorders and end-stage renal disease. Curr Opin Pulm Med 2008, 14(6):543-550.
• [19]Hanly PJ, Gabor JY, Chan C, Pierratos A: Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am J Kidney Dis 2003, 41(2):403-410.
• [20]American Academy of Sleep Medicine: The International Classification of Sleep Disorders, Diagnostic and Coding Manual, 2 edn. Weschester, Illinois: American Academy of Sleep Medicine, in association with the European Sleep Research Society, Japanese Society of Sleep Research, Latin American Sleep Society; 2005.
• [21]Douglas NJ, Thomas S, Jan MA: Clinical value of polysomnography. Lancet 1992, 339(8789):347-350.
• [22]Moul DE, Hall M, Pilkonis PA, Buysse DJ: Self-report measures of insomnia in adults: rationales, choices, and needs. Sleep Med Rev 2004, 8(3):177-198.
• [23]Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28(2):193-213.
• [24]Riegel B, Moelter ST, Ratcliffe SJ, Pressler SJ, De Geest S, Potashnik S, Fleck D, Sha D, Sayers SL, Weintraub WS, et al.: Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failure. J Card Fail 2011, 17(4):340-348.
• [25]Johns MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14(6):540-545.
• [26]Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40(5):373-383.
• [27]Buysse DJ, Germain A, Moul DE, Franzen PL, Brar LK, Fletcher ME, Begley A, Houck PR, Mazumdar S, Reynolds CF 3rd, et al.: Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med 2011, 171(10):887-895.
• [28]Germain A, Moul DE, Franzen PL, Miewald JM, Reynolds CF 3rd, Monk TH, Buysse DJ: Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med 2006, 2(4):403-406.
• [29]Buysse DJ: Diagnosis and assessment of sleep and circadian rhythm disorders. J Psychiatr Pract 2005, 11(2):102-115.
• [30]Moul DE, Nofzinger EA, Pilkonis PA, Houck PR, Miewald JM, Buysse DJ: Symptom reports in severe chronic insomnia. Sleep 2002, 25(5):553-563.
• [31]Van Dongen HP, Maislin G, Mullington JM, Dinges DF: The cumulative cost of additional wakefulness: dose–response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003, 26(2):117-126.
• [32]Mohammadpour N, Elyasi S, Vahdati N, Mohammadpour AH, Shamsara J: A review on therapeutic drug monitoring of immunosuppressant drugs. Iran J Basic Med Sci 2011, 14(6):485-498.
• [33]Ohayon MM, Lemoine P: Sleep and insomnia markers in the general population. Encéphale 2004, 30(2):135-140.
• [34]Lose G, Alling-Moller L, Jennum P: Nocturia in women. Am J Obstet Gynecol 2001, 185(2):514-521.
• [35]Asplund R: Pharmacotherapy for nocturia in the elderly patient. Drugs Aging 2007, 24(4):325-343.
• [36]Allen RE, Kirby KA: Nocturnal leg cramps. Am Fam Physician 2012, 86(4):350-355.
• [37]Wills L, Garcia J: Parasomnias: epidemiology and management. CNS Drugs 2002, 16(12):803-810.
• [38]Molnar MZ, Szentkiralyi A, Lindner A, Czira ME, Szeifert L, Kovacs AZ, Fornadi K, Szabo A, Rosivall L, Mucsi I, et al.: Restless legs syndrome and mortality in kidney transplant recipients. Am J Kidney Dis 2007, 50(5):813-820.
• [39]Beecroft JM, Zaltzman J, Prasad GV, Meliton G, Hanly PJ: Improvement of periodic limb movements following kidney transplantation. Nephron Clinical practice 2008, 109(3):c133-c139.
• [40]Rye DB, Trotti LM: Restless legs syndrome and periodic leg movements of sleep. Neurol Clin 2012, 30(4):1137-1166.
• [41]Nehlig A: Is caffeine a cognitive enhancer? J Alzheimers Dis 2010, 20(Suppl 1):S85-S94.
• [42]Cohen-Mansfield J, Perach R: Sleep duration, nap habits, and mortality in older persons. Sleep 2012, 35(7):1003-1009.
• [43]Picarsic JL, Glynn NW, Taylor CA, Katula JA, Goldman SE, Studenski SA, Newman AB: Self-reported napping and duration and quality of sleep in the lifestyle interventions and independence for elders - pilot study. J Am Geriatr Soc 2008, 56(9):1674-1680.
• [44]Milner CE, Cote KA: Benefits of napping in healthy adults: impact of nap length, time of day, age, and experience with napping. J Sleep Res 2009, 18(2):272-281.
• [45]Chan-Chee C, Bayon V, Bloch J, Beck F, Giordanella JP, Leger D: Epidemiology of insomnia in France. Revue d’epidemiologie et de sante publique 2011, 59(6):409-422.
• [46]Sack RL, Auckley D, Auger RR, Carskadon MA, Wright KP Jr, Vitiello MV, Zhdanova IV: Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review. Sleep 2007, 30(11):1484-1501.
• [47]Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, Lindner W: Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 1999, 55(2):111-115.
• [48]Murphy PJ, Myers BL, Badia P: Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav 1996, 59(1):133-139.
• [49]Roux FJ, Kryger MH: Medication effects on sleep. Clin Chest Med 2010, 31(2):397-405.
• [50]Almeida S, Filipe A, Neves R, Spinola AC, Tanguay M, Ortuno J, Farre A, Torns A: Mycophenolate mofetil 500-mg tablet under fasting conditions: single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects. Clin Ther 2010, 32(3):556-574.
• [51]Kugler C, Fischer S, Gottlieb J, Welte T, Simon A, Haverich A, Strueber M: Health-related quality of life in two hundred-eighty lung transplant recipients. J Heart Lung Transplant 2005, 24(12):2262-2268.
• [52]Molnar-Varga M, Molnar MZ, Szeifert L, Kovacs AZ, Kelemen A, Becze A, Laszlo G, Szentkiralyi A, Czira ME, Mucsi I, et al.: Health-related quality of life and clinical outcomes in kidney transplant recipients. Am J Kidney Dis 2011, 58(3):444-452.
• [53]Molnar MZ, Mucsi I, Novak M: Sleep disorders and qualiy of life in patients after kidney transplantation. In Sleep and quality of life in clinical medicine. edn. Edited by Vester JC. Totowa, NJ: Humana Press; 2008:401-409.
• [54]Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, Eccles MP, Cane J, Wood CE: The Behavior Change Technique Taxonomy (v1) of 93. Building an International Consensus for the Reporting of Behavior Change Interventions. Ann Beh Med: Hierarchically Clustered Techniques; 2013.
• [55]Troxel WM, Germain A, Buysse DJ: Clinical management of insomnia with brief behavioral treatment (BBTI). Behavioral sleep medicine 2012, 10(4):266-279.
• [56]Wirz-Justice A, Benedetti F, Terman M: Chronotherapeutics for affective disorders: a clinician’s manual for light and wake therapy. Basel: Karger; 2009.